China Arterial Cannula Market Size & Outlook, 2024-2030
China arterial cannula market, 2018-2030 (US$M)
Related Markets
China arterial cannula market highlights
- The China arterial cannula market generated a revenue of USD 1.6 million in 2023 and is expected to reach USD 2.4 million by 2030.
- The China market is expected to grow at a CAGR of 5.5% from 2024 to 2030.
- In terms of segment, veno-arterial was the largest revenue generating type in 2023.
- Veno-Arterial is the most lucrative type segment registering the fastest growth during the forecast period.
Arterial cannula market data book summary
| Market revenue in 2023 | USD 1.6 million |
| Market revenue in 2030 | USD 2.4 million |
| Growth rate | 5.5% (CAGR from 2023 to 2030) |
| Largest segment | Veno-arterial |
| Fastest growing segment | Veno-Arterial |
| Historical data | 2018 - 2022 |
| Base year | 2023 |
| Forecast period | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Veno-Arterial, Veno-Venous, Arterio-Venous |
| Key market players worldwide | Medtronic PLC, LivaNova PLC, Edwards Lifesciences Corp, Getinge AB ADR, Fresenius Medical Care AG, BD, Nipro Corp, Andocor, Surgical Holdings |
Other key industry trends
- In terms of revenue, China accounted for 5.0% of the global arterial cannula market in 2023.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In Asia Pacific, China arterial cannula market is projected to lead the regional market in terms of revenue in 2030.
- Japan is the fastest growing regional market in Asia Pacific and is projected to reach USD 2.0 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Arterial Cannula Market Scope
Arterial Cannula Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
China arterial cannula market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to arterial cannula market will help companies and investors design strategic landscapes.
Veno-arterial was the largest segment with a revenue share of 43.75% in 2024. Horizon Databook has segmented the China arterial cannula market based on veno-arterial, veno-venous, arterio-venous covering the revenue growth of each sub-segment from 2018 to 2030.
- China Arterial Cannula Type Outlook (Revenue, USD Million, 2018-2030)
- Veno-Arterial
- Veno-Venous
- Arterio-Venous
- China Arterial Cannula Patient Type Outlook (Revenue, USD Million, 2018-2030)
- Neonates
- Pediatric
- Adult
- China Arterial Cannula Application Outlook (Revenue, USD Million, 2018-2030)
- Respiratory
- Cardiac
- ECPR
- China Arterial Cannula End Use Outlook (Revenue, USD Million, 2018-2030)
- Hospitals
- Ambulatory Surgical Centers
- Others
Reasons to subscribe to China arterial cannula market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of China arterial cannula market databook
-
Our clientele includes a mix of arterial cannula market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the China arterial cannula market , including forecasts for subscribers. This country databook contains high-level insights into China arterial cannula market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
China arterial cannula market size, by type, 2018-2030 (US$M)
China Arterial Cannula Market Outlook Share, 2024 & 2030 (US$M)
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
